Clinical-grade Whole Genome Sequencing will become available in Q1 2019.
Yes! Everyone can use the Nebula platform to participate in surveys, share genomic data and earn Nebula credits. Our sequencing service will become available outside the United States by Q2 2019.
We use blockchain technology and multi-party access control, which means your data is encrypted with multiple keys, and those keys are held by different parties. This gives you full control over your data and makes data sharing transparent. For example, you may choose to be informed every time a researcher requests access to your data, and you can deny any such request. To protect the data that you decide to share, we will make sure that your data is anonymized and we will furthermore limit researchers’ access to it by implementing distributed, privacy-preserving computing.
You can purchase low-pass Whole Genome Sequencing now with Nebula credits that you earn by participating in surveys and referring friends. In the future, you will also have the opportunity to receive free clinical-grade Whole Genome Sequencing if you are matched with researchers who offer to pay your sequencing costs in order to earn access to your genomic data.
Yes. However, we advise against using low-pass Whole Genome Sequencing data to learn about your health. While an accuracy of ~99% might seem very high, some results will be erroneous if many genetic variants are interpreted and traits predicted. Please purchase clinical-grade Whole Genome sequencing from Nebula Genomics or other sequencing providers if you want to learn about your health.
Yes! You will be able to download your genomic data if you wish, in BAM and VCF formats, which are two of the most widely used formats for encoding genomic data.